References
- Graziano J H, Lolacono N J, Meyer P. Dose response study of oral 2, 3 dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr 1988; 113: 751–7
- Graziano J H, Lolacono N J, Moulton T, et al. Controlled study of meso-2, 3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 1992; 120: 133–9
- Chisolm J, Bal J. EDTA, DMSA and DMPS in the treatment of lead poisoning in children. J Toxicol Clin Toxicol 1992; 30: 493–504
- Liebelt E L, Shannon M, Graef J M. Efficacy of oral meso-2, 3-dimercaptosuccinic acid therapy for low-level childhood plumbism. J Pediatr 1994; 124: 313–17
- Meggs W J, Gerr F, Aly M H, et al. The treatment of lead poisoning from gunshot wounds with succimer (DMSA). J Toxicol Clin Toxicol 1994; 32: 377–85
- Graziano J H, Siris S E, Lolacono N J, et al. 2, 3-dimer-captosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther 1985; 37: 431–8
- Tutunjii M F, al-Mahasneh Q M. Disappearance of heme metabolites following chelation therapy with meso-2, 3-dimercaptosuccinic acid (DMSA). J Toxicol Clin Toxicol 1994; 32: 267–76
- Fernandez F J. Micromethod for lead determination in whole blood by atomic absorption with use of graphite furnace. Clin Chem 1975; 21: 558–60
- Preventing lead poisoning in young children. A statement by the Centers for Disease Control. Atlanta. October, 1991
- Chisolm J J, Jr. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. J Pediatr 1968; 73: 1–38
- Chisolm J J, Jr. Treatment of lead poisoning. Mod Treat 1971; 8: 593–611
- Foreman H, Trujillo T T. The metabolism of 14C labeled ethylenediaminetetraacetic acid in human beings. J Lab Clin Med 1953; 43: 566–71
- Graziano J H, Leong J K, Friedheim E. 2, 3-dimercapto-succinic acid: a new agent for the treatment of lead poisoning. Pharmacol Exp Ther 1978; 206: 696–700
- Friedheim E, Corvi C. Meso-dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning. J Pharmacol 1975; 27: 624–6
- Planas-Bohne F. The influence of chelating agents on the distribution and biotransformation of methlymercuric chloride in rats. J Pharmacol Exp Ther 1981; 217: 500–4
- Graziano J H, Cuccia D, Friedheim E. Potential usefulness of 2, 3-dimercatosuccinic acid for the treatment of arsenic poisoning. J Pharmacol Exp Ther 1978; 207: 1051–5
- Odonishnikova I E, Nirenberg V L. Absorption, distribution and excretion of 35S-labeled meso-dimercaptosuccinic acid (succimer). Vopr Eksp Klin Ter Profit Prom Intoksikatsii 1974; 1: 11–4
- Liang Y, Marlowe C, Wadell W J. Whole body autoradiographic distribution of (14C)-dimercaptosuccinic acid in mice. Pharmacologist 1982; 24: 217–20
- Dart R C, Hurlbut K M, Maiorino R M, Mayersohn M, Aposhian H V, Hassen L V. Pharmokinetics of meso-2, 3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. J Pediatr 1994; 125: 309–16
- Wang S C, Ting K S, Wu C C. Chelating therapy with NaDMSA in occupational lead and mercury intoxication. Chin Med J. 1965; 84: 437–9
- Bentur Y, Brook G, Behar R, et al. Meso-2, 3-dimercapto-succinic acid in the diagnosis and treatment of lead poisoning. J Toxicol Clin Toxicol 1987; 25: 39–51